China Pharmaceutical Contract Sales Organizations Market Size & Outlook
China pharmaceutical contract sales organizations market, 2018-2030 (US$M)
Related Markets
China pharmaceutical contract sales organizations market highlights
- The China pharmaceutical contract sales organizations market generated a revenue of USD 433.7 million in 2023 and is expected to reach USD 817.1 million by 2030.
- The China market is expected to grow at a CAGR of 9.5% from 2024 to 2030.
- In terms of segment, non-personal promotion was the largest revenue generating services in 2023.
- Non-personal promotion is the most lucrative services segment registering the fastest growth during the forecast period.
Pharmaceutical contract sales organizations market data book summary
| Market revenue in 2023 | USD 433.7 million |
| Market revenue in 2030 | USD 817.1 million |
| Growth rate | 9.5% (CAGR from 2023 to 2030) |
| Largest segment | Non-personal promotion |
| Fastest growing segment | Non-personal promotion |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Personal Promotion, Non-personal promotion |
| Key market players worldwide | Mobico Group PLC, IQVIA Holdings Inc, CMiC, EPS CORP, QFR Solutions, Mednext Pharma, Peak Pharma, Promoveo Health, Syneos Health |
Other key industry trends
- In terms of revenue, China accounted for 4.7% of the global pharmaceutical contract sales organizations market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan pharmaceutical contract sales organizations market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 817.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Contract Sales Organizations Market Scope
Pharmaceutical Contract Sales Organizations Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China pharmaceutical contract sales organizations market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical contract sales organizations market will help companies and investors design strategic landscapes.
Non-personal promotion was the largest segment with a revenue share of 55.59% in 2023. Horizon Databook has segmented the China pharmaceutical contract sales organizations market based on personal promotion, non-personal promotion covering the revenue growth of each sub-segment from 2018 to 2030.
- China Pharmaceutical Contract Sales Organizations Services Outlook (Revenue, USD Million, 2018-2030)
- Personal Promotion
- Promotional sales team
- Key account management
- Vacancy Management
- Non-personal promotion
- Medical affairs solutions
- Remote medical science liaisons
- Nurse (clinical) educators
- Others
- Personal Promotion
- China Pharmaceutical Contract Sales Organizations End-Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical companies
- Biopharmaceutical companies
Reasons to subscribe to China pharmaceutical contract sales organizations market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China pharmaceutical contract sales organizations market databook
-
Our clientele includes a mix of pharmaceutical contract sales organizations market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China pharmaceutical contract sales organizations market , including forecasts for subscribers. This country databook contains high-level insights into China pharmaceutical contract sales organizations market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China pharmaceutical contract sales organizations market outlook size, by services, 2018-2030 (US$M)
China Pharmaceutical Contract Sales Organizations Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
